Efficacy and safety on effects of ribavirin with sofosbuir and ledipasvir combination therapy for patients who failed to daclatasvir and asunaprevir combination therapy
Latest Information Update: 13 May 2016
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C; Liver cirrhosis
- Focus Therapeutic Use
Most Recent Events
- 13 May 2016 New trial record